- Email: [email protected]
Evaluation of the Th17 pathway in psoriasis and geographic tongue
+Model
ARTICLE IN PRESS
An Bras Dermatol. 2019;xxx(xx):xxx---xxx 1
Anais Brasileiros de
Dermatologia www.anaisdedermatologia.org.br
INVESTIGATION
Evaluation of the Th17 pathway in psoriasis and geographic tongue夽,夽夽
2
3
4
Q1
5 6
Bruna Lavinas Sayed Picciani a,∗ , Tábata Alves Domingos b , Thays Teixeira-Souza b , Anna Karoline Fausto-Silva b , Eliane Pedra Dias Sueli Carneiro c
b
,
a
9
Department of Pathology, Faculdade de Medicina, Universidade Federal Fluminense, Niterói, RJ, Brazil Graduate Program in Pathology, Faculdade de Medicina, Universidade Federal Fluminense, Niterói, RJ, Brazil c Sector of Dermatology, Medical Clinic Department, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
10
Received 25 September 2018; accepted 14 January 2019
7 8
11 12 13
Q2 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
b
KEYWORDS Glossitis; Benign migratory; Psoriasis; Th17 cells
Abstract Background: Psoriasis is a skin-articular disease with unclear etiopathogenesis. It has been suggested that the disease is immune-mediated by T-lymphocytes, predominantly Th17 cells. Similar to psoriasis, geographic tongue (GT) is an inflammatory disease with participation of Th17 cells and direct correlation with psoriasis. Objective: To investigate and compare the inflammatory responses and the Th17 pathway in psoriasis and geographic tongue. Methods: This was a cross-sectional study with 46 participants that were categorized into three groups: (A) patients with psoriasis vulgaris; (B) patients with geographic tongue and psoriasis; (C) patients with geographic tongue without psoriasis. All patients underwent physical examination, and a skin and oral biopsy for histopathological examination and immunohistochemical analysis with anti-IL6, anti-IL17, and anti-IL23 antibodies. Results: Histological analysis of all lesions showed mononuclear inflammatory infiltrate. However, moderate intensity was prevalent for the patients with geographic tongue and psoriasis and geographic tongue groups. Immunopositivity for the antibodies anti-IL6, anti-IL17, and antiIL23 revealed cytoplasmic staining, mainly basal and parabasal, in both psoriasis and geographic tongue. Regarding IL-6, in patients with geographic tongue and psoriasis cases the staining was stronger than in patients with geographic tongue without psoriasis cases. IL-17 evidenced more pronounced and extensive staining when compared to the other analyzed interleukins. IL-23 presented similar immunopositivity for both geographic tongue and psoriasis, demonstrating that the neutrophils recruited into the epithelium were stained.
夽 How to cite this article: Picciani BL, Domingos TA, Teixeira-Souza T, Fausto-Silva AK, Dias EP, Carneiro S. Evaluation of the Th17 pathway in psoriasis and geographic tongue. An Bras Dermatol. 2019;94. 夽夽 Study conducted at the Postgraduate Program in Pathology, Faculdade de Medicina, Universidade Federal Fluminense, Niterói, RJ, Brazil. ∗ Corresponding author. E-mail: [email protected] (B.L. Picciani).
https://doi.org/10.1016/j.abd.2019.01.006 0365-0596/© 2019 Published by Elsevier Espa˜ na, S.L.U. on behalf of Sociedade Brasileira de Dermatologia. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
ABD 78 1---7
+Model
ARTICLE IN PRESS
2
Study limitation: This study was limited by the number of cases. Conclusion: The inflammatory process and immunostaining of IL-6, IL-17, and IL-23 were similar in geographic tongue and psoriasis, suggesting the existence of a type of geographic tongue that represents an oral manifestation of psoriasis. © 2019 Published by Elsevier Espa˜ na, S.L.U. on behalf of Sociedade Brasileira de Dermatologia. This is an open access article under the CC BY license (http://creativecommons.org/licenses/ by/4.0/).
32 33 34 35 36 37 38
39
40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74
75
76 77 78 79 80 81 82 83 84 85
Picciani BL et al.
Introduction Psoriasis is a chronic immune-mediated inflammatory disease that affects 1% to 3% of the population worldwide.1 Although its etiology is unknown, it is believed that it is an immunological disease with genetic basis, being characterized by an inappropriate immunological activation triggered by T-lymphocytes, predominantly Th1 and Th17.2,3 Interleukins (IL) 17 and 23 are responsible for the development and maintenance Th17 cells, acting in production of IL-22 and IL-6, which stimulate keratinocyte proliferation. These findings regarding high levels of interleukins in the skin lesions of psoriasis patients provide tools for increasing interest about IL-23 and Th17 in psoriasis.2,4,5 Psoriasis presents variable expressivity according to the genetic component and environmental factors, which could affect other locations such as the oral mucosa.6---8 The oral lesion most strongly associated with psoriasis is geographic tongue (GT), characterized by irregular areas of loss of filiform papillae, often circumscribed by a yellowish-white line.8---10 Similar to psoriasis, GT is a chronic inflammatory disease with a genetic and immunological basis that has been described to have also a role of IL-6 and IL-17 in its development.10---13 The occurrence of oral manifestations of psoriasis is seldom reported in the literature; its clinical, histological, and immunogenetic similarities with GT creates controversial thoughts about the actual existence of an oral lesion caused by psoriasis or whether GT might be a marker which indicates the severity of skin disease, since these lesions are found more often in severe psoriasis.8,9,14---19 Thus, further studies are needed to better understand the pathogenesis and association between theses conditions. The aim of this study was to investigate and compare inflammatory responses and the Th17 pathway through evolution of the expression of IL-6, IL-17, and IL-23 in psoriasis and GT.
Methods This was a cross-sectional study, with 46 participants aged greater than 18 years, with clinical diagnosis of psoriasis vulgaris and GT. Based on the dermatological and stomatological examinations, the participants were categorized into three groups: (A) PV, consisting of 11 patients with psoriasis vulgaris; (B) PV-GT, consisting of 15 patients with GT and psoriasis vulgaris; and (C) NPS, consisting of 20 patients with GT without psoriasis. The subjects were excluded if they had other skin diseases, autoimmune diseases, metabolic diseases, severe cardiovascular diseases,
infections by hepatitis virus B or C or HIV, use of immunosuppressive medications, allergies, or possibility of a pregnancy at the time of evaluation. All patients underwent anamnesis; physical examination and a 5-mm skin punch and oral biopsy for histopathological examination and immunohistochemical analysis of anti-IL-6, anti-IL-17, and anti-IL-23 antibodies. The selection of the biopsy area was based on physical examination. Patients with psoriasis vulgaris had the biopsy performed on typical lesions, which are well-demarcated erythematousdesquamative plaques with silvery scales. Patients with GT had the biopsy performed in areas with white border and the atrophic area. After surgical removal, the tissue fragments were fixed in 10% phosphate-buffered formaldehyde and included in paraffin blocks. A glass slide stained with hematoxylin and eosin was prepared for histopathological analysis of the inflammatory response. The slides stained with hematoxylin and eosin were scanned at 40× magnification using an ultra-resolution ScanScopeTM system (Aperio Technologies --- CA, United States) and analyzed with detailed description of all histological alterations. A qualitative and quantitative analysis was conducted, and the predominant cell type (polymorphonuclear or mononuclear) and intensity of inflammatory infiltrate were evaluated. For intensity classification, all scanned slides were analyzed and the one with the most intense inflammatory infiltrate was selected. At 40× magnification, the most cellular area was captured and the cells were manually counted using an auxiliary grid, totalling 360 cells. Thereby, this total number was divided by three, establishing that at 40× magnification the inflammatory infiltrate of the most cellular area would be considered mild if under 120 cells, moderate if between 120 and 240 cells, and intense if above 240 cells. Subsequently, tissue fragments from paraffin blocks were organized into tissue macroarray (TMaA) paraffin blocks to perform immunohistochemistry (IHC) and further analyses. The study was approved by the Research Ethics Committee (02330258000-10), and all participants signed an informed consent.
TMaA construction
86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125
126
To construct the TMaA blocks, donor paraffin blocks containing skin fragments were grouped according to the psoriasis type. Fragments were removed from the donor blocks, placed in identified cassettes, and immersed in a liquid paraffin bath at 57 ◦ C. Metallic molds were prepared to receive the identified fragments. For this, a thin layer of liquid paraffin was placed on a metallic mold for the tissue’s adhesion. After the attachment of the tissues on the ABD 78 1---7
127 128 129 130 131 132 133 134
+Model
ARTICLE IN PRESS
Evaluation of the Th17 pathway in psoriasis and geographic tongue 135 136 137 138 139
140
141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163
164
165 166 167 168 169 170 171 172 173 174 175 176 177
178
179 180 181 182 183 184 185
metallic mold, using anatomical forceps, liquid paraffin was gently inserted to construct the paraffin blocks. Three TMaA paraffin blocks were constructed; the donor paraffin blocks. For each paraffin block, 5-m sections were collected on positively charged glass slides for IHC.20
IHC Expression of IL-6, IL-17, and IL-23 was demonstrated immunohistochemically using the immunoperoxidase technique. Primary antibodies used were: mouse monoclonal anti-human IL-6 (Abcam, ab9324; United States; dilution 1:8000), mouse monoclonal anti-human IL-17 (Abcam, ab79056; United States; dilution 1:1500), and mouse monoclonal anti-human IL-23 (Abcam, ab115759; United States; dilution 1:1000). After deparaffinization and rehydration, endogenous peroxidase activity was blocked with 3% hydrogen peroxide for 30 min. Antigen retrieval was performed with citrate buffer (pH 6.0) in a water bath (96 ◦ C) for 40 min. Non-specific protein binding was blocked with serum-free protein block (for 15 min). Sections were incubated for 10 h in a moist chamber at 4 ◦ C with the primary antibodies. The slides were subsequently incubated with the Dako EnVision+Dual Link System-HRP (Dako, K4061; United States) for 30 min. Visualization was performed by incubation for 3 min in a liquid 3,3 diaminobenzidine chromogen system (Dako, K3468;). Sections were counterstained with Harris hematoxylin. A tonsil fragment was used as positive control for the antibody anti-IL-6, lymph node for anti-IL-17, and kidney for anti-IL-23. Negative controls were performed by omission of the primary antibody.
IHC analysis Digital images of IHC-stained TMaA slides were obtained at 40× magnification using the Aperio CS2 scanner (Leica Biosystems --- United States). After that, the sections were visualized by ImageScopeTM software (Leica Biosystems --- United States) with subsequent analysis of all fragments. The protein expression of IL-6, IL-17, and IL23 was shown by the cytoplasmic-positive marking on keratinocytes, inflammatory cells, endothelial cells, and fibroblasts. The immunohistochemistry analysis was conducted in a qualitative and quantitative way, considering the pattern, localization, intensity, and extension of staining. Areas unsuitable for analysis, such as tissue-folds and other artifacts, were excluded.
Statistical analysis All statistical tests were performed using SPSS v. 22.0. Categorical variables were reported as proportions, and numeric variables were shown as median, mean, standard deviation (SD), and range. To evaluate the difference among two or more categorical variables, Fisher’s exact test was applied. The level of statistical significance for all analyses was set at 5% (p < 0.05).
3
Results
186
The age of the 46 participants included in this study ranged between 18 and 85 years, with an average of 52 years (SD = 15), showing a slight preference for the female sex, with 27 (58%) cases. Considering skin lesions of psoriatic patients, the superficial inflammatory infiltrate was predominantly mononuclear in 100% of cases. The infiltrate intensity varied among the patients, being moderate in six (54%) patients, mild in three (37%), and intense in two (19%). The comparative analysis of histological criteria between GT and skin lesions in patients with and without psoriasis revealed that both lesions presented inflammatory infiltrate, predominantly mononuclear. However, moderate intensity predominated in patients with GT and psoriasis, and patients exclusively with psoriasis; p = 0.078 (Table 1) (Fig. 1). The immunostaining of the three antibodies (anti-IL-6, anti-IL-17, and anti-IL-23) presented a similar cytoplasmic staining pattern, predominantly basal and parabasal, in both GT and psoriasis. When the basal layer was significantly more hyperplasic, the staining was more prominent and extensive. The mononuclear inflammatory infiltrate showed the same pattern of staining for all used antibodies. Concerning IL-6, in skin lesions there was immunopositivity in the basal third of the epithelium, being proportional to hyperplasia of the basal layer. The epithelial staining was stronger in regions presenting more intense hyperkeratosis. The immunopositivity in the dermis was seen in mononuclear inflammatory infiltrate, especially lymphocytes, as well as in the vascular endothelium. The staining was more intense in GT patients with psoriasis than in those with GT and without psoriasis. This might be because the former presented more prominent basal-layer hyperplasia, resembling the skin pattern (Fig. 2). IL-17 presented more evident and extensive staining when compared to the other interleukins evaluated. In skin lesions there was immunopositivity in the two inferior thirds of epidermis, even though some areas showed extension to the superficial layer due to intense hyperplasia. The staining pattern was more homogeneous, intense, and extensive in all fragments when compared to anti-IL-6 staining. In GT patients with psoriasis, the immunostaining pattern was similar to that in GT patients non-affected by psoriasis. However, this staining was less intense than in the skin lesions, and there was no significant difference between the two patterns, as was found for IL-6 staining. In non-psoriatic patients with GT, the immunostaining pattern found was more similar to that found in skin lesions (Fig. 2). IL-23 presented basal and suprabasal immunopositivity in skin lesions, extending to the superficial layers from the epithelium and being more intense and extensive than IL6 staining. The neutrophils infiltrated into the epithelium (Munro’s microabscesses) were also stained with this antibody. In the dermis, there was positivity in the mononuclear infiltrate and endothelium, similar to the other antibodies used. In GT patients, either with or without psoriasis, the staining pattern was substantially the same as that found in psoriasis lesions, with basal and suprabasal predominance, more intense and extensive than that of IL-6; the neutrophils in the epithelium were also stained, though less intensely than in skin staining (Fig. 2). ABD 78 1---7
187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246
+Model
ARTICLE IN PRESS
4
Picciani BL et al. Table 1 Histological aspects of oral and cutaneous lesions of patients presenting geographic tongue, geographic tongue and psoriasis, or isolated psoriasis. Histological aspects
Geographic tongue without psoriasis, n = 20 (%)
Geographic tongue with psoriasis, n = 15 (%)
Psoriasis, n = 11 (%)
Superficial inflammatory infiltrate Mononuclear Polymorphonuclear Inflammatory infiltrate intensity Mild Moderate Intense
--19 (95%) 1 (5%) --9 (45%) 5 (25%) 6 (30%)
--15 (100%) ----2 (13%) 11 (74%) 2 (13%)
----11 (100%) --3 (27%) 6 (55%) 2 (18%)
a
pa 0.514
0.078
Fisher’s exact test.
Figure 1 Histopathological aspects of inflammatory infiltrate (hematoxylin & eosin, ×40): A, Psoriasis with moderate infiltrate; B, Psoriasis with mild infiltrate; C, Geographic tongue in psoriatic patient with moderate infiltrate; D, Geographic tongue with mild infiltrate.
247
248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267
Discussion Psoriasis is a common skin-articular disease, immunologically triggered by T-lymphocytes, with production of cytokines types Th1 and Th17.1,3 The Th17 pathway has been associated with immunopathogenesis of psoriasis and other immune-mediated diseases such as GT.13 Several authors suggest an association between these two conditions. Besides the high prevalence in psoriatic patients, GT has clinical, etiologic, microscopic, and genetic similarities with psoriasis.8,9,14---19 As some patients present GT with no psoriasis, it is difficult for some authors to accept this oral condition as a manifestation of psoriasis.18,21---23 Moreover, there are only a few studies on the histological and immunohistochemical aspects of GT and its correlation with the skin disease. In the reviewed literature, there were no studies evaluating the inflammatory aspects of GT compared to psoriasis. The microscopic findings of psoriasis are very characteristic, such as the following: regular increase of the spinous layer with thickening of the lower portions; thickening and swelling of the papillae; parakeratosis; absence
of the granular layer; presence of Munro’s microabscesses; suprapapillary hypotrophy, occasionally presenting a small spongiform pustule; and inflammatory cell infiltration, mainly T-lymphocytes, macrophages, and neutrophils, in the dermis and submucosa.8,24,25 Such features can be also found in GT.8,26 The present study proposes a comparative analysis focused on inflammatory response in which the type and intensity of inflammatory infiltrate was evaluated in GT and psoriasis. Both conditions presented mononuclear inflammatory infiltrate predominance, and moderate intensity was prevalent in psoriasis and in psoriatic patients with GT. The inflammatory infiltrate has been highlighted in psoriasis, being particularly composed by T-lymphocytes.27 Also, the present authors have not found studies presenting this analysis in the literature encountered. In 2001, Femiano performed a histological evaluation, comparing GT lesions in psoriatic and non-psoriatic patients. The former group presented analyses histologically compatible with psoriasis. In the latter group, the same characteristics were observed in 80% of the individuals. Thus, the author considered GT as an oral manifestation of psoriasis, but suggested the possibility of having another
ABD 78 1---7
268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289
+Model
ARTICLE IN PRESS
Evaluation of the Th17 pathway in psoriasis and geographic tongue
5
Figure 2 Immunohistochemical marking aspects of interleukins in psoriasis and geographic tongue: Interleukin-6 --- A, Psoriasis; B, Geographic tongue in psoriatic patient; C, Geographic tongue. Interleukin-17 --- D, Psoriasis; E, Geographic tongue in psoriatic patient; F, Geographic tongue. Interleukin-23 --- G, Psoriasis; H, Geographic tongue in psoriatic patient; I, Geographic tongue.
290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323
type of GT non-associated with psoriasis.26 Although the histologic differences found in the present study are discreet, it corroborates the theory formulated by Femiano, in 2001, of another type of GT in non-psoriatic patients. The immunohistochemical analysis was directed to the immunoreactivity of antibodies anti-IL-6, anti-IL-17, and anti-IL-23 in both GT and psoriasis. In the present study, this analysis evidenced similarity in the distribution and quantity of immunopositive cells in both skin and oral lesions, reinforcing the association between them. In 2000, Goodman et al. evaluated the expression of IL-6 in psoriatic lesional, non-lesional, and normal tissues, revealing higher expression in lesional psoriatic skin than in non-lesional areas and normal skin. Additionally, predominance of IL-6 was observed in the papillae, superficial vascular plexus, and epidermal keratinocytes.28 In 1989, Grossman et al. evidenced immunoreactivity for anti-IL6 in keratinocytes, endothelial cells, and in most of the dermal infiltrate into psoriasis plaques. There was cytoplasmic staining in all cases, and in some cases there was also nuclear and membrane staining. The keratinocytes from the basal layer were more intensely stained than those from the spinous layer.29 The present study revealed similarities among the three groups that presented the same pattern of immunopositivity in endothelial cells, keratinocytes, and dermal inflammatory infiltrate, showing cytoplasmic staining, predominantly in the basal and suprabasal layers. In 2014, Alikhani et al. analyzed TNF-␣ and IL-6 concentration in the saliva of patients with GT and showed a significant increase in these cytokines in this lesion. Those authors concluded that GT is an inflammatory and immune-mediated condition, reinforcing its association with psoriasis.11 About 15 years ago, the expression of IL-17 was detected in skin fragments of psoriatic patients, whilst it was not
evidenced in normal control tissues, suggesting the involvement of IL-17 in psoriasis immunopathogenesis.30 IL-17 is the homonymous cytokine produced by the Th17 subgroups of T-lymphocytes.4,30 In 2010, Li Zhang et al. conducted an immunohistochemical analysis of IL-17 in 24 skin fragments from psoriasis, confirming this interleukin was significantly higher in these patients than in healthy individuals, being correlated to the disease severity. That study indicates IL-17 as a proinflammatory cytokine able to amplify the development of cutaneous inflammation and maintain the support of chronic dermatitis through keratinocyte stimulation.31 The current study demonstrated that IL-17 is present in large numbers in the mononuclear inflammatory infiltrate, besides the immunopositivity in basal and suprabasal keratinocytes from the epithelial hyperplasia and vascular endothelium areas. This occurs because keratinocytes are part of the immune system as well as the endothelial cells, playing a central role in the activation of pathways involved in psoriasis immunopathogenesis, acting firstly as an antigen presenting to T-lymphocytes.32---34 Herein, the same as in psoriasis, the intense staining of IL-17 in GT demonstrates that this interleukin is also involved in the pathogenesis of this oral lesion. In 2017, Baron reported a case of GT associated with acrodermatitis continua of Hallopeau with good outcome to secukinumab, a selective anti-IL-17A monoclonal antibody.13 This finding corroborates with the theory that IL-17 is involved in both conditions. Regarding IL-23, it is a key cytokine involved in the protective immune response to bacterial and fungal infections, even though its uncontrolled production may also promote inflammatory autoimmunity.2,35 Laboratory studies have identified the IL-23/IL-17 axis as the primary signaling pathway leading to characteristic molecular, cellular,
ABD 78 1---7
324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357
+Model
ARTICLE IN PRESS
6
Picciani BL et al. Anna Karoline Fausto-Silva: Approval of the final version of the manuscript; elaboration and writing of the manuscript; obtaining, analyzing and interpreting the data; critical review of the literature; critical review of the manuscript. Eliane Pedra Dias: Approval of the final version of the manuscript; conception and planning of the study; obtaining, analyzing and interpreting the data; critical review of the manuscript. Sueli Carneiro: Approval of the final version of the manuscript; conception and planning of the study; elaboration and writing of the manuscript; obtaining, analyzing and interpreting the data; effective participation in research orientation; critical review of the literature; critical review of the manuscript.
389
and structural changes in psoriatic skin. In the presence of IL-23, secreted mainly from inflammatory dermal dendritic cells (DCs), Th17 cells increase in number and produce large amounts of IL-17, which drive the upregulation of many psoriasis-related genes produced by epidermal keratinocytes. In addition to dermal DCs, epidermal keratinocytes and dermal macrophages are also found to produce IL-23 and may contribute to the pathogenesis and maintenance of psoriatic lesions. New research findings indicate that IL-23 is one of the most important cytokines in the pathogenesis of psoriasis.2,35 In 2016, Song et al. demonstrated, by immunohistochemistry, that IL-23 and IL-17 expressions were observed in the epidermis and perivascular dermal area in the psoriasis, suggesting that these interleukins play an important role in this disease.36 In the present study, a more intense staining of IL-17 was observed; however, IL-23 also showed similar staining, confirming the link between these two interleukins. In response to IL-23, these Th17 cells create an immune environment that triggers hyperproliferation of keratinocytes and leads to the recruitment of other immune cells.1,35 Furthermore, the present study demonstrated --- for the first time --- the involvement of this interleukin in GT, and the staining of neutrophils with IL-23, mainly in Munro’s microabscess areas. It has been described that neutrophils in the initial phase of the psoriatic lesion reach the epidermis, constituting Munro’s microabscess. Neutrophils are known for their relevant production of pro-inflammatory mediators and, since these cells express IL-17 receptors, IL-17 may represent an import signal of autocrine auto-amplification. Moreover, neutrophils respond to IL-23, which leads to an increased number of IL-17+ and IL-23+ neutrophils in psoriasis.2
390
Conclusion
References
358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388
398
This study shows that the inflammatory response and immunostaining of IL-6, IL-17, and IL-23 are often similar in both GT and psoriasis, reinforcing the possibility that there is a type of GT that represents an oral manifestation of psoriasis. Therefore, the Th17 pathway seems to play a central role in GT, regardless of the presence of psoriasis. Further studies are necessary for a better understanding of the role of the Th17 pathway in the pathogenesis of GT.
399
Author’s contribution
391 392 393 394 395 396 397
400 401 402 403 404 405 406 407 408 409 410 411 412 413 414
Bruna Lavinas Sayed Picciani: Statistical analysis; approval of the final version of the manuscript; conception and planning of the study; elaboration and writing of the manuscript; obtaining, analyzing and interpreting the data; effective participation in research orientation; intellectual participation in propaedeutic and/or therapeutic conduct of the cases studied; critical review of the literature; critical review of the manuscript. Tábata Alves Domingos: Elaboration and writing of the manuscript; obtaining, analyzing and interpreting the data; critical review of the manuscript. Thays Teixeira-Souza: Elaboration and writing of the manuscript; obtaining, analyzing and interpreting the data; critical review of the literature; critical review of the manuscript.
Financial support
415 416 417 418 419 420 421 422 423 424 425 426 427 428 429
430
FUNADERM --- Sociedade Brasileira de Dermatologia/Brazilian Society of Dermatology.
431 432
Conflicts of interest
433
None declared.
434
Acknowledgments
435
The authors would like to thank the Brazilian agencies CAPES and FUNADERM --- Sociedade Brasileira de Dermatologia/Brazilian Society of Dermatology --- for the financial support.
436 437 438 439
440
1. Eberle FC, Brück J, Holstein J, Hirahara K, Ghoreschi K. Recent advances in understanding psoriasis. F1000Res. 2016;5:F1000. 2. Chiricozzi A, Romanelli P, Volpe E, Borsellino G, Romanelli M. Scanning the immunopathogenesis of psoriasis. Int J Mol Sci. 2018:19---E179. 3. Harden JL, Krueger JG, Bowcock AM. The immunogenetics of psoriasis: a comprehensive review. J Autoimmun. 2015;64:66---73. 4. Torres T, Filipe P. Interleukin-17 as a therapeutic target in psoriasis. Acta Med Port. 2014;27:252---8. 5. Chiricozzi A. Pathogenic role of IL-17 in psoriasis and psoriatic arthritis. Actas Dermosifiliogr. 2014;105 Suppl. 1:9---20. 6. Gonzaga HF, Chaves MD, Gonzaga LH, Picciani BL, Jorge MA, Dias EP, et al. Environmental factors in benign migratory glossitis and psoriasis: retrospective study of the association of emotional stress and alcohol and tobacco consumption with benign migratory glossitis and cutaneous psoriasis. J Eur Acad Dermatol Venereol. 2015;29:533---6. 7. Jorge MA, Gonzaga HFS, Tomimori J, Picciani BLS, Barbosa CA. Prevalence and heritability of psoriasis and benign migratory glossitis in one Brazilian population. An Bras Dermatol. 2017;92:816---9. 8. Picciani BL, Domingos TA, Teixeira-Souza T, Santos VdC, Gonzaga HF, Cardoso-Oliveira J, et al. Geographic tongue and psoriasis: clinical, histopathological, immunohistochemical and genetic correlation --- a literature review. An Bras Dermatol. 2016;91:410---21. 9. Picciani B, Santos VC, Teixeira-Souza T, Izahias LM, Curty Á, Avelleira JC, et al. Investigation of the clinical features of
ABD 78 1---7
441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469
+Model
ARTICLE IN PRESS
Evaluation of the Th17 pathway in psoriasis and geographic tongue 470 471 472
10.
473 474
11.
475 476 477 478
12.
479 480 481 482
13.
483 484 485
14.
486 487 488 489
15.
490 491 492 493
16.
494 495 496
17.
497 498
18.
499 500
19.
501 502 503 504 505
20.
506 507
21.
508 509 510
22.
511 512 513 514
23.
geographic tongue: unveiling its relationship with oral psoriasis. Int J Dermatol. 2017;56:421---7. Jainkittivong A, Langlais RP. Geographic tongue: clinical characteristics of 188 cases. J Contemp Dent Pract. 2005;6:123---35. Alikhani M, Khalighinejad N, Ghalaiani P, Khaleghi MA, Askari E, Gorsky M. Immunologic and psychologic parameters associated with geographic tongue. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:68---71. Guimarães AL, Correia-Silva Jde F, Diniz MG, Xavier GM, Horta MC, Gomez RS. Investigation of functional gene polymorphisms: IL-1B, IL-6 and TNFA in benign migratory glossitis in Brazilian individuals. J Oral Pathol Med. 2007;36:533---7. Baron JA. Acrodermatitis of Hallopeau and erosive oral mucositis successfully treated with secukinumab. JAAD Case Rep. 2017;3:215---8. Picciani BL, Carneiro S, Sampaio AL, Santos BM, Santos VC, Gonzaga HF, et al. A possible relationship of human leucocyte antigens with psoriasis vulgaris and geographic tongue. J Eur Acad Dermatol Venereol. 2015;29:865---74. Picciani BL, Souza TT, Santos Vde C, Domingos TA, Carneiro S, Avelleira JC, et al. Geographic tongue and fissured tongue in 348 patients with psoriasis: correlation with disease severity. Sci World J. 2015;2015:564326. Abe M, Sogabe Y, Syuto T, Ishibuchi H, Yokoyama Y, Ishikawa O. Successful treatment with cyclosporin administration for persistent benign migratory glossitis. J Dermatol. 2007;34:340---3. Fatahzadeh M, Schwartz RA. Oral psoriasis: an overlooked enigma. Dermatology. 2016;232:319---25. Yesudian PD, Chalmers RJ, Warren RB, Griffiths CE. In search of oral psoriasis. Arch Dermatol Res. 2012;304:1---5. Talaee R, Hajheydari Z, Moghaddam AY, Moraveji SA, Ravandi BF. Prevalence of oral mucosal lesions and their association with severity of psoriasis among psoriatic patients referred to dermatology clinic: a cross-sectional study in Kashan/Iran. Open Access Maced J Med Sci. 2017;5:978---82. Dias EP, Picciani BLS, Santos VCBD, Cunha KS. A simple technique to construct tissue macroarrays. J Clin Pathol. 2018;7:890---4. Daneshpazhooh M, Moslehi H, Akhyani M, Etesami M. Tongue lesions in psoriasis: a controlled study. BMC Dermatol. 2004;4:16. Migliari DA, Penha SS, Marques MM, Matthews RW. Considerations on the diagnosis of oral psoriasis: a case report. Med Oral. 2004;9:300---3. Younai FS, Phelan JA. Oral mucositis with features of psoriasis: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84:61---7.
7
24. Ferreli C, Pinna AL, Pilloni L, Tomasini CF, Rongioletti F. Histopathological aspects of psoriasis and its uncommon variants. G Ital Dermatol Venereol. 2018;153:173---84. 25. Moorchung N, Khullar J, Mani N, Chatterjee M, Vasudevan B, Tripathi T. A Study of various histopathological features and their relevance in pathogenesis of psoriasis. Indian J Dermatol. 2013;58:294---8. 26. Femiano F. Geographic tongue (migrant glossitis) and psoriasis. Minerva Stomatol. 2001;50:213---7. 27. Wolberink EA, van Erp PE, Teussink MM, van de Kerkhof PC, Gerritsen MJ. Cellular features of psoriatic skin: imaging and quantification using in vivo reflectance confocal microscopy. Cytometry B Clin Cytom. 2011;80:141---9. 28. Goodman WA, Levine AD, Massari JV, Sugiyama H, McCormick TS, Cooper KD. IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J Immunol. 2009;183:3170---6. 29. Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, et al. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci U S A. 1989;86:6367---71. 30. Teunissen MB, Koomen CW, de Waal Malefyt R, Wierenga EA, Bos JD. Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol. 1998;111:645---9. 31. Zhang L, Yang XQ, Cheng J, Hui RS, Gao TW. Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity. Clin Immunol. 2010;135:108---17. 32. Lima Ede A, Lima Mde A. Reviewing concepts in the immunopathogenesis of psoriasis. An Bras Dermatol. 2011;86:1151---8. 33. Bressan AL, Pereira D, Medeiros PM, Carneiro S, Azulay-Abulafia L. How relevant are vascular endothelial growth factor and intercellular adhesion molecule in the systemic capillary leak syndrome of psoriasis? An Bras Dermatol. 2017;92:826---9. 34. Bressan AL, Picciani BLS, Azulay-Abulafia L, Fausto-Silva AK, Almeida PN, Cunha KSG, et al. Evaluation of ICAM-1 expression and vascular changes in the skin of patients with plaque, pustular, and erythrodermic psoriasis. Int J Dermatol. 2018;57:209---16. 35. Fotiadou C, Lazaridou E, Sotiriou E, Ioannides D. Targeting IL-23 in psoriasis: current perspectives. Psoriasis (Auckl). 2018;8:1---5. 36. Song HS, Kim SJ, Park TI, Jang YH, Lee ES. Immunohistochemical comparison of IL-36 and the IL-23/Th17 axis of generalized pustular psoriasis and acute generalized exanthematous pustulosis. Ann Dermatol. 2016;28:451---6.
ABD 78 1---7
515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560
ARTICLE IN PRESS
An Bras Dermatol. 2019;xxx(xx):xxx---xxx 1
Anais Brasileiros de
Dermatologia www.anaisdedermatologia.org.br
INVESTIGATION
Evaluation of the Th17 pathway in psoriasis and geographic tongue夽,夽夽
2
3
4
Q1
5 6
Bruna Lavinas Sayed Picciani a,∗ , Tábata Alves Domingos b , Thays Teixeira-Souza b , Anna Karoline Fausto-Silva b , Eliane Pedra Dias Sueli Carneiro c
b
,
a
9
Department of Pathology, Faculdade de Medicina, Universidade Federal Fluminense, Niterói, RJ, Brazil Graduate Program in Pathology, Faculdade de Medicina, Universidade Federal Fluminense, Niterói, RJ, Brazil c Sector of Dermatology, Medical Clinic Department, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
10
Received 25 September 2018; accepted 14 January 2019
7 8
11 12 13
Q2 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
b
KEYWORDS Glossitis; Benign migratory; Psoriasis; Th17 cells
Abstract Background: Psoriasis is a skin-articular disease with unclear etiopathogenesis. It has been suggested that the disease is immune-mediated by T-lymphocytes, predominantly Th17 cells. Similar to psoriasis, geographic tongue (GT) is an inflammatory disease with participation of Th17 cells and direct correlation with psoriasis. Objective: To investigate and compare the inflammatory responses and the Th17 pathway in psoriasis and geographic tongue. Methods: This was a cross-sectional study with 46 participants that were categorized into three groups: (A) patients with psoriasis vulgaris; (B) patients with geographic tongue and psoriasis; (C) patients with geographic tongue without psoriasis. All patients underwent physical examination, and a skin and oral biopsy for histopathological examination and immunohistochemical analysis with anti-IL6, anti-IL17, and anti-IL23 antibodies. Results: Histological analysis of all lesions showed mononuclear inflammatory infiltrate. However, moderate intensity was prevalent for the patients with geographic tongue and psoriasis and geographic tongue groups. Immunopositivity for the antibodies anti-IL6, anti-IL17, and antiIL23 revealed cytoplasmic staining, mainly basal and parabasal, in both psoriasis and geographic tongue. Regarding IL-6, in patients with geographic tongue and psoriasis cases the staining was stronger than in patients with geographic tongue without psoriasis cases. IL-17 evidenced more pronounced and extensive staining when compared to the other analyzed interleukins. IL-23 presented similar immunopositivity for both geographic tongue and psoriasis, demonstrating that the neutrophils recruited into the epithelium were stained.
夽 How to cite this article: Picciani BL, Domingos TA, Teixeira-Souza T, Fausto-Silva AK, Dias EP, Carneiro S. Evaluation of the Th17 pathway in psoriasis and geographic tongue. An Bras Dermatol. 2019;94. 夽夽 Study conducted at the Postgraduate Program in Pathology, Faculdade de Medicina, Universidade Federal Fluminense, Niterói, RJ, Brazil. ∗ Corresponding author. E-mail: [email protected] (B.L. Picciani).
https://doi.org/10.1016/j.abd.2019.01.006 0365-0596/© 2019 Published by Elsevier Espa˜ na, S.L.U. on behalf of Sociedade Brasileira de Dermatologia. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
ABD 78 1---7
+Model
ARTICLE IN PRESS
2
Study limitation: This study was limited by the number of cases. Conclusion: The inflammatory process and immunostaining of IL-6, IL-17, and IL-23 were similar in geographic tongue and psoriasis, suggesting the existence of a type of geographic tongue that represents an oral manifestation of psoriasis. © 2019 Published by Elsevier Espa˜ na, S.L.U. on behalf of Sociedade Brasileira de Dermatologia. This is an open access article under the CC BY license (http://creativecommons.org/licenses/ by/4.0/).
32 33 34 35 36 37 38
39
40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74
75
76 77 78 79 80 81 82 83 84 85
Picciani BL et al.
Introduction Psoriasis is a chronic immune-mediated inflammatory disease that affects 1% to 3% of the population worldwide.1 Although its etiology is unknown, it is believed that it is an immunological disease with genetic basis, being characterized by an inappropriate immunological activation triggered by T-lymphocytes, predominantly Th1 and Th17.2,3 Interleukins (IL) 17 and 23 are responsible for the development and maintenance Th17 cells, acting in production of IL-22 and IL-6, which stimulate keratinocyte proliferation. These findings regarding high levels of interleukins in the skin lesions of psoriasis patients provide tools for increasing interest about IL-23 and Th17 in psoriasis.2,4,5 Psoriasis presents variable expressivity according to the genetic component and environmental factors, which could affect other locations such as the oral mucosa.6---8 The oral lesion most strongly associated with psoriasis is geographic tongue (GT), characterized by irregular areas of loss of filiform papillae, often circumscribed by a yellowish-white line.8---10 Similar to psoriasis, GT is a chronic inflammatory disease with a genetic and immunological basis that has been described to have also a role of IL-6 and IL-17 in its development.10---13 The occurrence of oral manifestations of psoriasis is seldom reported in the literature; its clinical, histological, and immunogenetic similarities with GT creates controversial thoughts about the actual existence of an oral lesion caused by psoriasis or whether GT might be a marker which indicates the severity of skin disease, since these lesions are found more often in severe psoriasis.8,9,14---19 Thus, further studies are needed to better understand the pathogenesis and association between theses conditions. The aim of this study was to investigate and compare inflammatory responses and the Th17 pathway through evolution of the expression of IL-6, IL-17, and IL-23 in psoriasis and GT.
Methods This was a cross-sectional study, with 46 participants aged greater than 18 years, with clinical diagnosis of psoriasis vulgaris and GT. Based on the dermatological and stomatological examinations, the participants were categorized into three groups: (A) PV, consisting of 11 patients with psoriasis vulgaris; (B) PV-GT, consisting of 15 patients with GT and psoriasis vulgaris; and (C) NPS, consisting of 20 patients with GT without psoriasis. The subjects were excluded if they had other skin diseases, autoimmune diseases, metabolic diseases, severe cardiovascular diseases,
infections by hepatitis virus B or C or HIV, use of immunosuppressive medications, allergies, or possibility of a pregnancy at the time of evaluation. All patients underwent anamnesis; physical examination and a 5-mm skin punch and oral biopsy for histopathological examination and immunohistochemical analysis of anti-IL-6, anti-IL-17, and anti-IL-23 antibodies. The selection of the biopsy area was based on physical examination. Patients with psoriasis vulgaris had the biopsy performed on typical lesions, which are well-demarcated erythematousdesquamative plaques with silvery scales. Patients with GT had the biopsy performed in areas with white border and the atrophic area. After surgical removal, the tissue fragments were fixed in 10% phosphate-buffered formaldehyde and included in paraffin blocks. A glass slide stained with hematoxylin and eosin was prepared for histopathological analysis of the inflammatory response. The slides stained with hematoxylin and eosin were scanned at 40× magnification using an ultra-resolution ScanScopeTM system (Aperio Technologies --- CA, United States) and analyzed with detailed description of all histological alterations. A qualitative and quantitative analysis was conducted, and the predominant cell type (polymorphonuclear or mononuclear) and intensity of inflammatory infiltrate were evaluated. For intensity classification, all scanned slides were analyzed and the one with the most intense inflammatory infiltrate was selected. At 40× magnification, the most cellular area was captured and the cells were manually counted using an auxiliary grid, totalling 360 cells. Thereby, this total number was divided by three, establishing that at 40× magnification the inflammatory infiltrate of the most cellular area would be considered mild if under 120 cells, moderate if between 120 and 240 cells, and intense if above 240 cells. Subsequently, tissue fragments from paraffin blocks were organized into tissue macroarray (TMaA) paraffin blocks to perform immunohistochemistry (IHC) and further analyses. The study was approved by the Research Ethics Committee (02330258000-10), and all participants signed an informed consent.
TMaA construction
86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125
126
To construct the TMaA blocks, donor paraffin blocks containing skin fragments were grouped according to the psoriasis type. Fragments were removed from the donor blocks, placed in identified cassettes, and immersed in a liquid paraffin bath at 57 ◦ C. Metallic molds were prepared to receive the identified fragments. For this, a thin layer of liquid paraffin was placed on a metallic mold for the tissue’s adhesion. After the attachment of the tissues on the ABD 78 1---7
127 128 129 130 131 132 133 134
+Model
ARTICLE IN PRESS
Evaluation of the Th17 pathway in psoriasis and geographic tongue 135 136 137 138 139
140
141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163
164
165 166 167 168 169 170 171 172 173 174 175 176 177
178
179 180 181 182 183 184 185
metallic mold, using anatomical forceps, liquid paraffin was gently inserted to construct the paraffin blocks. Three TMaA paraffin blocks were constructed; the donor paraffin blocks. For each paraffin block, 5-m sections were collected on positively charged glass slides for IHC.20
IHC Expression of IL-6, IL-17, and IL-23 was demonstrated immunohistochemically using the immunoperoxidase technique. Primary antibodies used were: mouse monoclonal anti-human IL-6 (Abcam, ab9324; United States; dilution 1:8000), mouse monoclonal anti-human IL-17 (Abcam, ab79056; United States; dilution 1:1500), and mouse monoclonal anti-human IL-23 (Abcam, ab115759; United States; dilution 1:1000). After deparaffinization and rehydration, endogenous peroxidase activity was blocked with 3% hydrogen peroxide for 30 min. Antigen retrieval was performed with citrate buffer (pH 6.0) in a water bath (96 ◦ C) for 40 min. Non-specific protein binding was blocked with serum-free protein block (for 15 min). Sections were incubated for 10 h in a moist chamber at 4 ◦ C with the primary antibodies. The slides were subsequently incubated with the Dako EnVision+Dual Link System-HRP (Dako, K4061; United States) for 30 min. Visualization was performed by incubation for 3 min in a liquid 3,3 diaminobenzidine chromogen system (Dako, K3468;). Sections were counterstained with Harris hematoxylin. A tonsil fragment was used as positive control for the antibody anti-IL-6, lymph node for anti-IL-17, and kidney for anti-IL-23. Negative controls were performed by omission of the primary antibody.
IHC analysis Digital images of IHC-stained TMaA slides were obtained at 40× magnification using the Aperio CS2 scanner (Leica Biosystems --- United States). After that, the sections were visualized by ImageScopeTM software (Leica Biosystems --- United States) with subsequent analysis of all fragments. The protein expression of IL-6, IL-17, and IL23 was shown by the cytoplasmic-positive marking on keratinocytes, inflammatory cells, endothelial cells, and fibroblasts. The immunohistochemistry analysis was conducted in a qualitative and quantitative way, considering the pattern, localization, intensity, and extension of staining. Areas unsuitable for analysis, such as tissue-folds and other artifacts, were excluded.
Statistical analysis All statistical tests were performed using SPSS v. 22.0. Categorical variables were reported as proportions, and numeric variables were shown as median, mean, standard deviation (SD), and range. To evaluate the difference among two or more categorical variables, Fisher’s exact test was applied. The level of statistical significance for all analyses was set at 5% (p < 0.05).
3
Results
186
The age of the 46 participants included in this study ranged between 18 and 85 years, with an average of 52 years (SD = 15), showing a slight preference for the female sex, with 27 (58%) cases. Considering skin lesions of psoriatic patients, the superficial inflammatory infiltrate was predominantly mononuclear in 100% of cases. The infiltrate intensity varied among the patients, being moderate in six (54%) patients, mild in three (37%), and intense in two (19%). The comparative analysis of histological criteria between GT and skin lesions in patients with and without psoriasis revealed that both lesions presented inflammatory infiltrate, predominantly mononuclear. However, moderate intensity predominated in patients with GT and psoriasis, and patients exclusively with psoriasis; p = 0.078 (Table 1) (Fig. 1). The immunostaining of the three antibodies (anti-IL-6, anti-IL-17, and anti-IL-23) presented a similar cytoplasmic staining pattern, predominantly basal and parabasal, in both GT and psoriasis. When the basal layer was significantly more hyperplasic, the staining was more prominent and extensive. The mononuclear inflammatory infiltrate showed the same pattern of staining for all used antibodies. Concerning IL-6, in skin lesions there was immunopositivity in the basal third of the epithelium, being proportional to hyperplasia of the basal layer. The epithelial staining was stronger in regions presenting more intense hyperkeratosis. The immunopositivity in the dermis was seen in mononuclear inflammatory infiltrate, especially lymphocytes, as well as in the vascular endothelium. The staining was more intense in GT patients with psoriasis than in those with GT and without psoriasis. This might be because the former presented more prominent basal-layer hyperplasia, resembling the skin pattern (Fig. 2). IL-17 presented more evident and extensive staining when compared to the other interleukins evaluated. In skin lesions there was immunopositivity in the two inferior thirds of epidermis, even though some areas showed extension to the superficial layer due to intense hyperplasia. The staining pattern was more homogeneous, intense, and extensive in all fragments when compared to anti-IL-6 staining. In GT patients with psoriasis, the immunostaining pattern was similar to that in GT patients non-affected by psoriasis. However, this staining was less intense than in the skin lesions, and there was no significant difference between the two patterns, as was found for IL-6 staining. In non-psoriatic patients with GT, the immunostaining pattern found was more similar to that found in skin lesions (Fig. 2). IL-23 presented basal and suprabasal immunopositivity in skin lesions, extending to the superficial layers from the epithelium and being more intense and extensive than IL6 staining. The neutrophils infiltrated into the epithelium (Munro’s microabscesses) were also stained with this antibody. In the dermis, there was positivity in the mononuclear infiltrate and endothelium, similar to the other antibodies used. In GT patients, either with or without psoriasis, the staining pattern was substantially the same as that found in psoriasis lesions, with basal and suprabasal predominance, more intense and extensive than that of IL-6; the neutrophils in the epithelium were also stained, though less intensely than in skin staining (Fig. 2). ABD 78 1---7
187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246
+Model
ARTICLE IN PRESS
4
Picciani BL et al. Table 1 Histological aspects of oral and cutaneous lesions of patients presenting geographic tongue, geographic tongue and psoriasis, or isolated psoriasis. Histological aspects
Geographic tongue without psoriasis, n = 20 (%)
Geographic tongue with psoriasis, n = 15 (%)
Psoriasis, n = 11 (%)
Superficial inflammatory infiltrate Mononuclear Polymorphonuclear Inflammatory infiltrate intensity Mild Moderate Intense
--19 (95%) 1 (5%) --9 (45%) 5 (25%) 6 (30%)
--15 (100%) ----2 (13%) 11 (74%) 2 (13%)
----11 (100%) --3 (27%) 6 (55%) 2 (18%)
a
pa 0.514
0.078
Fisher’s exact test.
Figure 1 Histopathological aspects of inflammatory infiltrate (hematoxylin & eosin, ×40): A, Psoriasis with moderate infiltrate; B, Psoriasis with mild infiltrate; C, Geographic tongue in psoriatic patient with moderate infiltrate; D, Geographic tongue with mild infiltrate.
247
248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267
Discussion Psoriasis is a common skin-articular disease, immunologically triggered by T-lymphocytes, with production of cytokines types Th1 and Th17.1,3 The Th17 pathway has been associated with immunopathogenesis of psoriasis and other immune-mediated diseases such as GT.13 Several authors suggest an association between these two conditions. Besides the high prevalence in psoriatic patients, GT has clinical, etiologic, microscopic, and genetic similarities with psoriasis.8,9,14---19 As some patients present GT with no psoriasis, it is difficult for some authors to accept this oral condition as a manifestation of psoriasis.18,21---23 Moreover, there are only a few studies on the histological and immunohistochemical aspects of GT and its correlation with the skin disease. In the reviewed literature, there were no studies evaluating the inflammatory aspects of GT compared to psoriasis. The microscopic findings of psoriasis are very characteristic, such as the following: regular increase of the spinous layer with thickening of the lower portions; thickening and swelling of the papillae; parakeratosis; absence
of the granular layer; presence of Munro’s microabscesses; suprapapillary hypotrophy, occasionally presenting a small spongiform pustule; and inflammatory cell infiltration, mainly T-lymphocytes, macrophages, and neutrophils, in the dermis and submucosa.8,24,25 Such features can be also found in GT.8,26 The present study proposes a comparative analysis focused on inflammatory response in which the type and intensity of inflammatory infiltrate was evaluated in GT and psoriasis. Both conditions presented mononuclear inflammatory infiltrate predominance, and moderate intensity was prevalent in psoriasis and in psoriatic patients with GT. The inflammatory infiltrate has been highlighted in psoriasis, being particularly composed by T-lymphocytes.27 Also, the present authors have not found studies presenting this analysis in the literature encountered. In 2001, Femiano performed a histological evaluation, comparing GT lesions in psoriatic and non-psoriatic patients. The former group presented analyses histologically compatible with psoriasis. In the latter group, the same characteristics were observed in 80% of the individuals. Thus, the author considered GT as an oral manifestation of psoriasis, but suggested the possibility of having another
ABD 78 1---7
268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289
+Model
ARTICLE IN PRESS
Evaluation of the Th17 pathway in psoriasis and geographic tongue
5
Figure 2 Immunohistochemical marking aspects of interleukins in psoriasis and geographic tongue: Interleukin-6 --- A, Psoriasis; B, Geographic tongue in psoriatic patient; C, Geographic tongue. Interleukin-17 --- D, Psoriasis; E, Geographic tongue in psoriatic patient; F, Geographic tongue. Interleukin-23 --- G, Psoriasis; H, Geographic tongue in psoriatic patient; I, Geographic tongue.
290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323
type of GT non-associated with psoriasis.26 Although the histologic differences found in the present study are discreet, it corroborates the theory formulated by Femiano, in 2001, of another type of GT in non-psoriatic patients. The immunohistochemical analysis was directed to the immunoreactivity of antibodies anti-IL-6, anti-IL-17, and anti-IL-23 in both GT and psoriasis. In the present study, this analysis evidenced similarity in the distribution and quantity of immunopositive cells in both skin and oral lesions, reinforcing the association between them. In 2000, Goodman et al. evaluated the expression of IL-6 in psoriatic lesional, non-lesional, and normal tissues, revealing higher expression in lesional psoriatic skin than in non-lesional areas and normal skin. Additionally, predominance of IL-6 was observed in the papillae, superficial vascular plexus, and epidermal keratinocytes.28 In 1989, Grossman et al. evidenced immunoreactivity for anti-IL6 in keratinocytes, endothelial cells, and in most of the dermal infiltrate into psoriasis plaques. There was cytoplasmic staining in all cases, and in some cases there was also nuclear and membrane staining. The keratinocytes from the basal layer were more intensely stained than those from the spinous layer.29 The present study revealed similarities among the three groups that presented the same pattern of immunopositivity in endothelial cells, keratinocytes, and dermal inflammatory infiltrate, showing cytoplasmic staining, predominantly in the basal and suprabasal layers. In 2014, Alikhani et al. analyzed TNF-␣ and IL-6 concentration in the saliva of patients with GT and showed a significant increase in these cytokines in this lesion. Those authors concluded that GT is an inflammatory and immune-mediated condition, reinforcing its association with psoriasis.11 About 15 years ago, the expression of IL-17 was detected in skin fragments of psoriatic patients, whilst it was not
evidenced in normal control tissues, suggesting the involvement of IL-17 in psoriasis immunopathogenesis.30 IL-17 is the homonymous cytokine produced by the Th17 subgroups of T-lymphocytes.4,30 In 2010, Li Zhang et al. conducted an immunohistochemical analysis of IL-17 in 24 skin fragments from psoriasis, confirming this interleukin was significantly higher in these patients than in healthy individuals, being correlated to the disease severity. That study indicates IL-17 as a proinflammatory cytokine able to amplify the development of cutaneous inflammation and maintain the support of chronic dermatitis through keratinocyte stimulation.31 The current study demonstrated that IL-17 is present in large numbers in the mononuclear inflammatory infiltrate, besides the immunopositivity in basal and suprabasal keratinocytes from the epithelial hyperplasia and vascular endothelium areas. This occurs because keratinocytes are part of the immune system as well as the endothelial cells, playing a central role in the activation of pathways involved in psoriasis immunopathogenesis, acting firstly as an antigen presenting to T-lymphocytes.32---34 Herein, the same as in psoriasis, the intense staining of IL-17 in GT demonstrates that this interleukin is also involved in the pathogenesis of this oral lesion. In 2017, Baron reported a case of GT associated with acrodermatitis continua of Hallopeau with good outcome to secukinumab, a selective anti-IL-17A monoclonal antibody.13 This finding corroborates with the theory that IL-17 is involved in both conditions. Regarding IL-23, it is a key cytokine involved in the protective immune response to bacterial and fungal infections, even though its uncontrolled production may also promote inflammatory autoimmunity.2,35 Laboratory studies have identified the IL-23/IL-17 axis as the primary signaling pathway leading to characteristic molecular, cellular,
ABD 78 1---7
324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357
+Model
ARTICLE IN PRESS
6
Picciani BL et al. Anna Karoline Fausto-Silva: Approval of the final version of the manuscript; elaboration and writing of the manuscript; obtaining, analyzing and interpreting the data; critical review of the literature; critical review of the manuscript. Eliane Pedra Dias: Approval of the final version of the manuscript; conception and planning of the study; obtaining, analyzing and interpreting the data; critical review of the manuscript. Sueli Carneiro: Approval of the final version of the manuscript; conception and planning of the study; elaboration and writing of the manuscript; obtaining, analyzing and interpreting the data; effective participation in research orientation; critical review of the literature; critical review of the manuscript.
389
and structural changes in psoriatic skin. In the presence of IL-23, secreted mainly from inflammatory dermal dendritic cells (DCs), Th17 cells increase in number and produce large amounts of IL-17, which drive the upregulation of many psoriasis-related genes produced by epidermal keratinocytes. In addition to dermal DCs, epidermal keratinocytes and dermal macrophages are also found to produce IL-23 and may contribute to the pathogenesis and maintenance of psoriatic lesions. New research findings indicate that IL-23 is one of the most important cytokines in the pathogenesis of psoriasis.2,35 In 2016, Song et al. demonstrated, by immunohistochemistry, that IL-23 and IL-17 expressions were observed in the epidermis and perivascular dermal area in the psoriasis, suggesting that these interleukins play an important role in this disease.36 In the present study, a more intense staining of IL-17 was observed; however, IL-23 also showed similar staining, confirming the link between these two interleukins. In response to IL-23, these Th17 cells create an immune environment that triggers hyperproliferation of keratinocytes and leads to the recruitment of other immune cells.1,35 Furthermore, the present study demonstrated --- for the first time --- the involvement of this interleukin in GT, and the staining of neutrophils with IL-23, mainly in Munro’s microabscess areas. It has been described that neutrophils in the initial phase of the psoriatic lesion reach the epidermis, constituting Munro’s microabscess. Neutrophils are known for their relevant production of pro-inflammatory mediators and, since these cells express IL-17 receptors, IL-17 may represent an import signal of autocrine auto-amplification. Moreover, neutrophils respond to IL-23, which leads to an increased number of IL-17+ and IL-23+ neutrophils in psoriasis.2
390
Conclusion
References
358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388
398
This study shows that the inflammatory response and immunostaining of IL-6, IL-17, and IL-23 are often similar in both GT and psoriasis, reinforcing the possibility that there is a type of GT that represents an oral manifestation of psoriasis. Therefore, the Th17 pathway seems to play a central role in GT, regardless of the presence of psoriasis. Further studies are necessary for a better understanding of the role of the Th17 pathway in the pathogenesis of GT.
399
Author’s contribution
391 392 393 394 395 396 397
400 401 402 403 404 405 406 407 408 409 410 411 412 413 414
Bruna Lavinas Sayed Picciani: Statistical analysis; approval of the final version of the manuscript; conception and planning of the study; elaboration and writing of the manuscript; obtaining, analyzing and interpreting the data; effective participation in research orientation; intellectual participation in propaedeutic and/or therapeutic conduct of the cases studied; critical review of the literature; critical review of the manuscript. Tábata Alves Domingos: Elaboration and writing of the manuscript; obtaining, analyzing and interpreting the data; critical review of the manuscript. Thays Teixeira-Souza: Elaboration and writing of the manuscript; obtaining, analyzing and interpreting the data; critical review of the literature; critical review of the manuscript.
Financial support
415 416 417 418 419 420 421 422 423 424 425 426 427 428 429
430
FUNADERM --- Sociedade Brasileira de Dermatologia/Brazilian Society of Dermatology.
431 432
Conflicts of interest
433
None declared.
434
Acknowledgments
435
The authors would like to thank the Brazilian agencies CAPES and FUNADERM --- Sociedade Brasileira de Dermatologia/Brazilian Society of Dermatology --- for the financial support.
436 437 438 439
440
1. Eberle FC, Brück J, Holstein J, Hirahara K, Ghoreschi K. Recent advances in understanding psoriasis. F1000Res. 2016;5:F1000. 2. Chiricozzi A, Romanelli P, Volpe E, Borsellino G, Romanelli M. Scanning the immunopathogenesis of psoriasis. Int J Mol Sci. 2018:19---E179. 3. Harden JL, Krueger JG, Bowcock AM. The immunogenetics of psoriasis: a comprehensive review. J Autoimmun. 2015;64:66---73. 4. Torres T, Filipe P. Interleukin-17 as a therapeutic target in psoriasis. Acta Med Port. 2014;27:252---8. 5. Chiricozzi A. Pathogenic role of IL-17 in psoriasis and psoriatic arthritis. Actas Dermosifiliogr. 2014;105 Suppl. 1:9---20. 6. Gonzaga HF, Chaves MD, Gonzaga LH, Picciani BL, Jorge MA, Dias EP, et al. Environmental factors in benign migratory glossitis and psoriasis: retrospective study of the association of emotional stress and alcohol and tobacco consumption with benign migratory glossitis and cutaneous psoriasis. J Eur Acad Dermatol Venereol. 2015;29:533---6. 7. Jorge MA, Gonzaga HFS, Tomimori J, Picciani BLS, Barbosa CA. Prevalence and heritability of psoriasis and benign migratory glossitis in one Brazilian population. An Bras Dermatol. 2017;92:816---9. 8. Picciani BL, Domingos TA, Teixeira-Souza T, Santos VdC, Gonzaga HF, Cardoso-Oliveira J, et al. Geographic tongue and psoriasis: clinical, histopathological, immunohistochemical and genetic correlation --- a literature review. An Bras Dermatol. 2016;91:410---21. 9. Picciani B, Santos VC, Teixeira-Souza T, Izahias LM, Curty Á, Avelleira JC, et al. Investigation of the clinical features of
ABD 78 1---7
441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469
+Model
ARTICLE IN PRESS
Evaluation of the Th17 pathway in psoriasis and geographic tongue 470 471 472
10.
473 474
11.
475 476 477 478
12.
479 480 481 482
13.
483 484 485
14.
486 487 488 489
15.
490 491 492 493
16.
494 495 496
17.
497 498
18.
499 500
19.
501 502 503 504 505
20.
506 507
21.
508 509 510
22.
511 512 513 514
23.
geographic tongue: unveiling its relationship with oral psoriasis. Int J Dermatol. 2017;56:421---7. Jainkittivong A, Langlais RP. Geographic tongue: clinical characteristics of 188 cases. J Contemp Dent Pract. 2005;6:123---35. Alikhani M, Khalighinejad N, Ghalaiani P, Khaleghi MA, Askari E, Gorsky M. Immunologic and psychologic parameters associated with geographic tongue. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:68---71. Guimarães AL, Correia-Silva Jde F, Diniz MG, Xavier GM, Horta MC, Gomez RS. Investigation of functional gene polymorphisms: IL-1B, IL-6 and TNFA in benign migratory glossitis in Brazilian individuals. J Oral Pathol Med. 2007;36:533---7. Baron JA. Acrodermatitis of Hallopeau and erosive oral mucositis successfully treated with secukinumab. JAAD Case Rep. 2017;3:215---8. Picciani BL, Carneiro S, Sampaio AL, Santos BM, Santos VC, Gonzaga HF, et al. A possible relationship of human leucocyte antigens with psoriasis vulgaris and geographic tongue. J Eur Acad Dermatol Venereol. 2015;29:865---74. Picciani BL, Souza TT, Santos Vde C, Domingos TA, Carneiro S, Avelleira JC, et al. Geographic tongue and fissured tongue in 348 patients with psoriasis: correlation with disease severity. Sci World J. 2015;2015:564326. Abe M, Sogabe Y, Syuto T, Ishibuchi H, Yokoyama Y, Ishikawa O. Successful treatment with cyclosporin administration for persistent benign migratory glossitis. J Dermatol. 2007;34:340---3. Fatahzadeh M, Schwartz RA. Oral psoriasis: an overlooked enigma. Dermatology. 2016;232:319---25. Yesudian PD, Chalmers RJ, Warren RB, Griffiths CE. In search of oral psoriasis. Arch Dermatol Res. 2012;304:1---5. Talaee R, Hajheydari Z, Moghaddam AY, Moraveji SA, Ravandi BF. Prevalence of oral mucosal lesions and their association with severity of psoriasis among psoriatic patients referred to dermatology clinic: a cross-sectional study in Kashan/Iran. Open Access Maced J Med Sci. 2017;5:978---82. Dias EP, Picciani BLS, Santos VCBD, Cunha KS. A simple technique to construct tissue macroarrays. J Clin Pathol. 2018;7:890---4. Daneshpazhooh M, Moslehi H, Akhyani M, Etesami M. Tongue lesions in psoriasis: a controlled study. BMC Dermatol. 2004;4:16. Migliari DA, Penha SS, Marques MM, Matthews RW. Considerations on the diagnosis of oral psoriasis: a case report. Med Oral. 2004;9:300---3. Younai FS, Phelan JA. Oral mucositis with features of psoriasis: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84:61---7.
7
24. Ferreli C, Pinna AL, Pilloni L, Tomasini CF, Rongioletti F. Histopathological aspects of psoriasis and its uncommon variants. G Ital Dermatol Venereol. 2018;153:173---84. 25. Moorchung N, Khullar J, Mani N, Chatterjee M, Vasudevan B, Tripathi T. A Study of various histopathological features and their relevance in pathogenesis of psoriasis. Indian J Dermatol. 2013;58:294---8. 26. Femiano F. Geographic tongue (migrant glossitis) and psoriasis. Minerva Stomatol. 2001;50:213---7. 27. Wolberink EA, van Erp PE, Teussink MM, van de Kerkhof PC, Gerritsen MJ. Cellular features of psoriatic skin: imaging and quantification using in vivo reflectance confocal microscopy. Cytometry B Clin Cytom. 2011;80:141---9. 28. Goodman WA, Levine AD, Massari JV, Sugiyama H, McCormick TS, Cooper KD. IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J Immunol. 2009;183:3170---6. 29. Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, et al. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci U S A. 1989;86:6367---71. 30. Teunissen MB, Koomen CW, de Waal Malefyt R, Wierenga EA, Bos JD. Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol. 1998;111:645---9. 31. Zhang L, Yang XQ, Cheng J, Hui RS, Gao TW. Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity. Clin Immunol. 2010;135:108---17. 32. Lima Ede A, Lima Mde A. Reviewing concepts in the immunopathogenesis of psoriasis. An Bras Dermatol. 2011;86:1151---8. 33. Bressan AL, Pereira D, Medeiros PM, Carneiro S, Azulay-Abulafia L. How relevant are vascular endothelial growth factor and intercellular adhesion molecule in the systemic capillary leak syndrome of psoriasis? An Bras Dermatol. 2017;92:826---9. 34. Bressan AL, Picciani BLS, Azulay-Abulafia L, Fausto-Silva AK, Almeida PN, Cunha KSG, et al. Evaluation of ICAM-1 expression and vascular changes in the skin of patients with plaque, pustular, and erythrodermic psoriasis. Int J Dermatol. 2018;57:209---16. 35. Fotiadou C, Lazaridou E, Sotiriou E, Ioannides D. Targeting IL-23 in psoriasis: current perspectives. Psoriasis (Auckl). 2018;8:1---5. 36. Song HS, Kim SJ, Park TI, Jang YH, Lee ES. Immunohistochemical comparison of IL-36 and the IL-23/Th17 axis of generalized pustular psoriasis and acute generalized exanthematous pustulosis. Ann Dermatol. 2016;28:451---6.
ABD 78 1---7
515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560